Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Ejaculation
Interventions
DRUG

UK-390,957

Trial Locations (49)

Unknown

Pfizer Investigational Site, Bondi Junction

Pfizer Investigational Site, St Leonards

Pfizer Investigational Site, Spring Hill

Pfizer Investigational Site, Adelaide

Pfizer Investigational Site, Malvern

Pfizer Investigational Site, Nedlands

Pfizer Investigational Site, Mistelbach

Pfizer Investigational Site, Salzburg

Pfizer Investigational Site, Edmonton

Pfizer Investigational Site, Victoria

Pfizer Investigational Site, London

Pfizer Investigational Site, Oakville

Pfizer Investigational Site, Toronto

Pfizer Investigational Site, Montréal

Pfizer Investigational Site, Montreal

Pfizer Investigational Site, Brno

Pfizer Investigational Site, Hradec Králové

Pfizer Investigational Site, Prague

Pfizer Investigational Site, Le Kremlin-Bicêtre

Pfizer Investigational Site, Lyon

Pfizer Investigational Site, Munich

Pfizer Investigational Site, Hamburg

Pfizer Investigational Site, Hanover

Pfizer Investigational Site, München

Pfizer Investigational Site, Beersheba

Pfizer Investigational Site, Haifa

Pfizer Investigational Site, Jerusalem

Pfizer Investigational Site, Tel Aviv

Pfizer Investigational Site, Tel Litwinsky

Pfizer Investigational Site, Milan

Pfizer Investigational Site, Roma

Pfizer Investigational Site, Nijmegen

Pfizer Investigational Site, The Hague

Pfizer Investigational Site, Bodø

Pfizer Investigational Site, Moelv

Pfizer Investigational Site, Oslo

Pfizer Investigational Site, Bialystok

Pfizer Investigational Site, Kielce

Pfizer Investigational Site, Mysłowice

Pfizer Investigational Site, Warsaw

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Sabadell

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Málaga

Pfizer Investigational Site, Skövde

Pfizer Investigational Site, Stockholm

Pfizer Investigational Site, Balcali

Pfizer Investigational Site, Samanpazarı

Pfizer Investigational Site, Balçova

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00219583 - Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation | Biotech Hunter | Biotech Hunter